Agilent Announces End-to-End Digital Pathology Workflow Solution at USCAP 2023

The announcement coincides with the USCAP 112th Annual Meeting held March 11-16 at the New Orleans Ernest N. Morial Convention Center in New Orleans, Louisiana. "We are delighted to further extend our partnership in this emerging era of personalized medicine." The increasing prevalence of chronic conditions is predicted to intensify the urgency of pathologists seeking to adopt innovative digital pathology solutions to improve existing patient diagnostic imaging methods and reduce the high cost associated with traditional diagnostics. Technological advances in the past decade and the numerous benefits of digital pathology are driving the practice to become widely adopted. Agilent and Visiopharm have collaborated since 2020, developing an integrated solution comprising Visiopharm's portfolio of leading artificial intelligence (AI)-driven precision pathology software and Agilent's automated pathology staining solutions.